Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and […]
Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and […]
Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and […]
KIGALI, Rwanda, April 16, 2025 (GLOBE NEWSWIRE) — The Clinton Health Access Initiative (CHAI) and the OneSight EssilorLuxottica Foundation have announced a multi-year partnership to advance access to eyeglasses and build sustainable vision care systems across Africa. With a shared focus on health equity, the collaboration aims to address one of the continent’s most widespread […]